Buerger's disease future or investigational therapies: Difference between revisions
No edit summary |
m (Bot: Adding CME Category::Cardiology) |
||
Line 11: | Line 11: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Cardiovascular diseases]] | [[Category:Cardiovascular diseases]] |
Revision as of 06:00, 15 March 2016
Buerger's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Buerger's disease future or investigational therapies On the Web |
American Roentgen Ray Society Images of Buerger's disease future or investigational therapies |
FDA on Buerger's disease future or investigational therapies |
CDC on Buerger's disease future or investigational therapies |
Buerger's disease future or investigational therapies in the news |
Blogs on Buerger's disease future or investigational therapies |
Risk calculators and risk factors for Buerger's disease future or investigational therapies |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or Investigational Therapies
Use of vascular growth factor and stem cell injections have been showing promise in clinical studies.